Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Mandeep S Dhingra"'
Autor:
Suman Kanungo, Anna Lena Lopez, Mohammad Ali, Byomkesh Manna, Deok Ryon Kim, Tanmay Mahapatra, Jan Holmgren, Mandeep S Dhingra, Thomas F Weirzba, G Balakrish Nair, Sujit K Bhattacharya, John D Clemens, Dipika Sur
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96499 (2014)
During the development of a vaccine, identification of the correlates of protection is of paramount importance for establishing an objective criterion for the protective performance of the vaccine. However, the ascertainment of correlates of immunity
Externí odkaz:
https://doaj.org/article/0f99e47eaf4748f28a4ef9af80e52b4e
Autor:
Franco M. Piazza, Miia Virta, Marita Paassilta, Benita Ukkonen, Anitta Ahonen, Alejandra Esteves-Jaramillo, Aino Forsten, Ilkka Seppa, Jian Ding, David Neveu, Emilia Jordanov, Mandeep S. Dhingra
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1, Pp 1-10 (2022)
Booster doses of meningococcal conjugate vaccines induce long-term protection against invasive meningococcal disease. We evaluated the immunogenicity and safety of a booster dose of MenACYW-TT in pre-school children who were primed 3 years earlier wi
Externí odkaz:
https://doaj.org/article/ae4a5646612f43059f87c1e7dbd5ac14
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1299-1305 (2020)
MenACYW-TT is an investigational quadrivalent meningococcal conjugate vaccine intended for the prevention of invasive meningococcal disease (IMD) caused by serogroups A, C, W, and Y in individuals aged 6 weeks and above. This Phase II, randomized, op
Externí odkaz:
https://doaj.org/article/df15230868d743cebb351bdb4b3567c8
Autor:
Germán Áñez, James Hedrick, Michael W. Simon, Shane Christensen, Robert Jeanfreau, Eddy Yau, Judy Pan, Emilia Jordanov, Mandeep S. Dhingra
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1292-1298 (2020)
The quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) was assessed as a booster in this Phase III trial (NCT02752906). Quadrivalent meningococcal conjugate vaccine (MCV4)-primed individuals aged ≥15 y (n = 810) were randomize
Externí odkaz:
https://doaj.org/article/cc581208343a4f05909ba802da5ef51b
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1306-1312 (2020)
Neisseria meningitidis can lead to invasive meningococcal disease to which young children are particularly vulnerable. We assessed the immunogenicity and safety of Sanofi Pasteur’s investigational quadrivalent (serogroups A, C, Y, and W) meningococ
Externí odkaz:
https://doaj.org/article/b9f119a3196147769fb276bbc5eb8423
Autor:
Tarun Saluja, Mandeep S. Dhingra, Shiv D. Sharma, Madhu Gupta, Ritabrata Kundu, Sonali Kar, Ashok K. Dutta, Maria D. P. Silveira, Jai V. Singh, Veena G. Kamath, Anurag Chaudhary, Venkateswara Rao, Mandyam D. Ravi, Kesava Murthy, Rajesh Arumugam, Annick Moureau, Rajendra Prasad, Badri N. Patnaik
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 3, Pp 711-716 (2017)
Rotavirus is the leading cause of severe and dehydrating diarrhea in children aged under 5 years. We undertook this hospital-based surveillance study to examine the possible relationship between the severity of diarrhea and the various G-group rotavi
Externí odkaz:
https://doaj.org/article/6649717a0c7f46ea9e268d5c4cb1e905
Autor:
Matthew J. Cornish, James A. Hedrick, Alvin A. Gabrielsen, Anthony D. Johnson, L. Miriam Pina, Christine Rehm, Judy Pan, David Neveu, Xavier Da Costa, Emilia Jordanov, Mandeep S. Dhingra
Publikováno v:
Vaccine. 40:1421-1438
The MenACYW-TT conjugate vaccine is approved for prevention of invasive meningococcal disease (IMD) as a single dose in individuals ≥2 years of age in the United States and ≥12 months in EU and some other countries. This Phase II study evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93e43bc50ca2179dce13c846c8884dd1
https://doi.org/10.1016/j.vaccine.2022.01.050
https://doi.org/10.1016/j.vaccine.2022.01.050
Autor:
Emilia Jordanov, David Neveu, Benita Ukkonen, Marita Paassilta, Aino Forsten, Franco M. Piazza, Miia Virta, Alejandra Esteves-Jaramillo, Anitta Ahonen, Ilkka Seppa, Jian Ding, Mandeep S. Dhingra
Publikováno v:
Human Vaccines & Immunotherapeutics. 18:1-10
Booster doses of meningococcal conjugate vaccines induce long-term protection against invasive meningococcal disease. We evaluated the immunogenicity and safety of a booster dose of MenACYW-TT in pre-school children who were primed 3 years earlier wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c0edeb0b3fae467cd2c9d384d20ac09
https://doi.org/10.1080/21645515.2021.1902701
https://doi.org/10.1080/21645515.2021.1902701
Autor:
Shane Christensen, Donald Brandon, Mandeep S. Dhingra, Emilia Jordanov, Carmen Baccarini, Michael W. Simon
Publikováno v:
The Pediatric Infectious Disease Journal
Supplemental Digital Content is available in the text.
Background: Invasive meningococcal disease is a major cause of meningitis in children. An investigational meningococcal (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccine (MenACYW-
Background: Invasive meningococcal disease is a major cause of meningitis in children. An investigational meningococcal (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccine (MenACYW-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bf4db92977c9d7fd9424ba094b583de
http://europepmc.org/articles/PMC7497415
http://europepmc.org/articles/PMC7497415
Publikováno v:
Vaccine. 38:5194-5201
MenACYW-TT is an investigational quadrivalent (serogroups A, C, W and Y) meningococcal conjugate vaccine that is being developed for protection against invasive meningococcal disease.In this Phase 3, blinded, randomized study, 3344 meningococcal vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d95b7854484207752fd2b1009026e2
https://doi.org/10.1016/j.vaccine.2020.06.013
https://doi.org/10.1016/j.vaccine.2020.06.013